Education
About Us
Working with TipRanks
Follow Us
My Biotech Portfolio - New Portfolio
Grant Jiao
My Biotech PortfolioIndividual Investor
Ranked #653,502 out of 824,216 TipRanks' Investors
Success Rate
75 out of 209
profitable transactions
profitable transactions
Average Return
-16.21%
Average return
per transaction
per transaction
Share this portfolio:
Portfolio Gain
1-Month Return▲ 0.73%
6-Month Return▲ 55.30%
12-Month Return▲ 53.83%
YTD Return▲ 53.18%
Total Return▲ 8.95%
Best Trade
Bio
Focus on breakthrough biotech companies with long term appreciation opportunities
Performance
25.92%0-25.92%
▼ 6.38%
▼ 5.57%
▼ 5.69%
Mar 2025
▲ 0.80%
▼ 0.87%
▲ 5.58%
Apr 2025
▲ 11.63%
▲ 6.28%
▼ 10.99%
May 2025
▲ 9.25%
▲ 5.14%
▲ 25.92%
Jun 2025
▲ 7.60%
▲ 2.30%
▲ 4.34%
Jul 2025
▲ 2.76%
▲ 2.05%
▲ 13.43%
Aug 2025
▲ 12.88%
▲ 3.56%
▲ 4.86%
Sep 2025
▲ 4.43%
▲ 0.77%
▼ 2.97%
Oct 2025
▼ 6.38%▼ 5.57%▼ 5.69%
▲ 0.80%▼ 0.87%▲ 5.58%
▲ 11.63%▲ 6.28%▼ 10.99%
▲ 9.25%▲ 5.14%▲ 25.92%
▲ 7.60%▲ 2.30%▲ 4.34%
▲ 2.76%▲ 2.05%▲ 13.43%
▲ 12.88%▲ 3.56%▲ 4.86%
▲ 4.43%▲ 0.77%▼ 2.97%
Recent Activity
Kineta
―
▼ 99.04%
8
Close
Jun 30, 2025
TuHURA Biosciences
0.01%
▲ 9.87%
1
Open
Jun 30, 2025
Intra-Cellular Therapies
―
▲ 362.48%
8
Close
Apr 01, 2025
Marinus
―
▼ 96.03%
5
Close
Feb 10, 2025
Oncternal Therapeutics
―
▼ 99.53%
5
Close
Dec 02, 2024
TRACON Pharmaceuticals
―
▼ 37.40%
5
Close
Dec 02, 2024
Gamida Cell
―
▼ 99.83%
4
Close
May 24, 2024
Sio Gene Therapies
―
▼ 54.15%
5
Close
Feb 07, 2024
Zynerba Pharmaceuticals
―
▼ 65.80%
5
Close
Oct 10, 2023
Coherus Biosciences
0.54%
▼ 45.89%
4
Buy
Sep 11, 2023
Surface Oncology
―
▼ 87.14%
7
Close
Sep 11, 2023
Applied Genetic Technologies
―
▼ 92.22%
9
Close
Nov 30, 2022
Corvus Pharmaceuticals
0%
▲ 21.07%
1
Open
Sep 18, 2021
Palantir Technologies
0%
▲ 609.89%
1
Open
Sep 08, 2021
Atossa Therapeutics
0%
▼ 75.18%
1
Open
Jun 10, 2021
Ardelyx
0.12%
▼ 26.83%
2
Sell
Mar 20, 2021
Mirum Pharmaceuticals
17.8%
▲ 289.94%
7
Sell
Mar 20, 2021
Zevra Therapeutics
2.72%
▲ 25.63%
7
Sell
Mar 20, 2021
Curis
0.08%
▼ 94.42%
6
Sell
Mar 20, 2021
Carisma Therapeutics
0.01%
▼ 99.81%
6
Sell
Mar 20, 2021